Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response-Reference-Cited by-同舟云学术

Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response

Published:2007-12 Issue:6 Volume:46 Page:1695-1703
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Yuen Man-Fung,Fong Daniel Yee-Tak,Wong Danny Ka-Ho,Yuen John Chi-Hang,Fung James,Lai Ching-Lung

Publisher

Wiley

Subject

Hepatology

Reference27 articles.

1. Viral hepatitis B;Lai;Lancet,2003

2. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

3. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load;Iloeje;Gastroenterology,2006

4. Lamivudine for patients with chronic hepatitis B and advanced liver disease;Liaw;N Engl J Med,2004

5. Long-term beneficial outcome of Chinese asymptomatic patients with HBeAg-positive chronic hepatitis B on continuous lamivudine therapy: 7-year experience;Yuen;HEPATOLOGY,2005

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early dynamic changes of quasispecies in the reverse transcriptase region of hepatitis B virus in telbivudine treatment;Antiviral Research;2021-11

2. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2019-06-25

3. Step-down strategy in antiviral resistant chronic hepatitis B patients who achieved viral suppression with rescue combination therapy;Future Virology;2018-10-01

4. Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance;J MED VIROL;2018

5. Long-term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis;Journal of Viral Hepatitis;2017-10-29